In the last century, physiological techniques probing the nature of a neuromuscular transmission defect have been well established 1 . One of the most important is the electrophysiological test for the Lambert-Eaton myasthenic syndrome (LEMS). The main historical contribution for recognizing the physiological findings of this disease began when it was reported that patients with bronchial neoplasm and muscle weakness improved after removal of the tumor or after the use of anti-cholinesterase drugs, which suggested the concomitance of a neuromuscular transmission defect 2, 3 . In 1956, a series of patients with unusual disorders of neuromuscular transmission associated with a malignant tumor was presented by Lambert, Eaton and Rooke at an international meeting of the American Physiological Society, and a brief note published as an abstract 4 . In this series, many of the clinical and electrophysiological features were carefully distinguished from those seen in myasthenia gravis, which served as a basis for a publication one year later by Eaton and Lambert 4, 5 . This was one of the most important pioneering articles in LEMS 5 . In 1957, this groundbreaking article was published by Eaton and Lambert in The Journal of the American Medical Association (JAMA), summarizing the core features of myasthenic syndrome and later leading to the eponym for the disease 3, 5, 6 . Initially, the eponym was 'Eaton-Lambert syndrome' and 'Eaton-Lambert myasthenic syndrome', in reference to their pioneering work and publication in JAMA 6, 7, 8 . Recently, the eponym 'Lambert-Eaton myasthenic syndrome' (LEMS) was adopted in international publications in PubMed and other databases (July 2017), probably in honor to Lambert' s contributions to the establishment of the physiological basis of the defect in the neuromuscular transmission in this disease 7 .
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In recent years, our knowledge of the clinical and pathological features of LEMS has expanded; however, the core electrophysiological features of LEMS are identical to those in the Eaton and Lambert article. In November, 2017, this pioneering article was cited in 402 articles in the Google Scholar database, 304 articles in the Web of Science database and 198 articles in the Scopus database. In addition, in July 2017, the term LEMS could be identified in more than 1,000 articles in the PubMed database.
Both neurologists are most renowned for describing the LEMS, but they also have contributed to a wide range of electrophysiological tests and neuromuscular diseases 1, 7 . When their article was published, Dr. Lee M. Eaton was affiliated to the Section of Neurology (Chair of the Neurology Department at the Mayo Clinic) and Dr. Edward H. Lambert to the Section of Physiology of the Mayo Clinic and Mayo Foundation (the Mayo Foundation was part of the graduate school of the University of Minnesota) 5 . This review describes historical aspects of the important contribution made by Drs. Lee M. Eaton and Edward H. Lambert to this disease in 1957 with their pioneering article in JAMA.
EATON AND LAMBERT'S PIONEERING ARTICLE
In the introduction of the article, the authors commented that several inquiries had been made about the clinical value of electromyography and nerve conduction studies, which reflected a 'broad interest among physicians'
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. Although these procedures were previously well studied by other authors, electrophysiological tests were not widely adopted by neurologists in the middle of last century 1 
.
To describe the test to the medical community, especially to neurologists, the article provided a detailed description of the ' electrophysiology of muscle contraction', the procedures of ' electromyographic testing', the 'value of clinical electromyography' and the importance of the additional ' electric stimulation of nerves' in the investigation of neuromuscular disorders 5 . The argument that these procedures ' also may be used as instruments of research' was explored in the article, and the authors selected examples of diseases to show the usefulness of the procedures in clinical research 5 . The most important was the description of six patients 'who have a disorder resembling myasthenia gravis, which may represent a specific clinical electromyographic syndrome' 5 . The authors described three patients presenting with weakness (mainly in the lower limbs) associated with fatigability and absence of the muscle stretch reflexes 5 . The results of the neostigmine test were negative or equivocal 5 . All the patients had a thoracic tumor, and small cell lung carcinoma was diagnosed in two of them 5 . However, the electromyography studies revealed an 'unusual fatigability' of muscles in all the patients 5 .
Additional electrophysiological and clinical studies were done, which, although similar to those in myasthenia gravis in all patients, revealed significant differences as well
' Application of a single electric stimulus to the ulnar nerve resulted in a much smaller action potential of the hypothenar muscles than would have been expected on the basis of the relatively good strength of the muscles as determined clinically. This had been observed in all the patients of this group and was in contrast to the occurrence of a relatively normal response to a single stimulus in patients with myasthenia gravis of comparable severity. A series of stimuli resulted in a further transient decrease in amplitude of the potential, followed by a remarkable increase in the size of subsequent potentials, with comparable increase in the strength of the resulting twitches'.
Eaton and Lambert also confessed that their academic curiosity 'was aroused sufficiently' to search for similar cases in their records 5 . Three other patients were found with the same features 5 . Two patients had a thoracic tumor and one patient had cerebellar ataxia without an association with a tumor 5 .
The authors commented that neurological diseases, especially neuromuscular disorders, had recently been reported to be associated with malignant tumors 5 . They reflected particularly on published cases that could have similar characteristics to the new syndrome 2, 5 : 'Some of the reported cases, particularly those classified as myopathy, appear to be clinically similar, if not identical, to those that have interested us. In the case reported by Anderson and co-workers, electromyographic and pharmacological studies gave results similar to those seen in myasthenia gravis. However, in general, the English authors have not elaborated on the electromyographic features of the syndrome that, in our experience, seem to be of considerable diagnostic importance'.
This pioneering article is also important because it served to present the considerable clinical potential of the electrophysiological techniques in LEMS to a scientific and medical readership 9 . The authors elegantly highlighted the value of repetitive nerve stimulation in the LEMS diagnosis 5 : 'Should this syndrome prove to be of some clinical importance, electromyography and stimulation of nerves must be given the greatest credit. Without these techniques, the syndrome would have been confused with myasthenia gravis and its significance would have continued to elude us'.
Eaton and Lambert's article summarized the main clinical features in detail, and established the electrophysiological criteria of LEMS. The electrophysiological criteria were characterized in the comments that highlight the 'marked facilitation' (incremental response of the compound muscular action potential) after high-frequency repetitive nerve stimulation and voluntary contraction, the identification of which was an important landmark for LEMS and electrophysiological tests 5 . The incremental response was not quantified in the article. Further recommendations added that increments greater than 100% should be observed as more accurate (gold standard) to confirm the diagnosis of LEMS 10 . Even after 60 years, the main electrophysiological criteria for LEMS described in Eaton and Lambert's pioneering article are still useful in the LEMS diagnosis.
